BROADWOOD CAPITAL INC
Follow13F filer, CIK 1278387, New York, NY
BROADWOOD CAPITAL INC reported $1,234,437,659 across 8 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-15.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000919574-25-003088
- Period
- 2025-03-31
- Reported value
- $1.23B
- Holdings
- 8
- Top 10 weight
- 100%
- New
- 1
- Sold out
- 0
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| STAAadded | +1,606,633 | $28.3M |
| IMDXadded | +5,165,695 | $15.8M |
| OLO INCnew | +1,782,334 | $10.8M |
| LCTXadded | +7,894,737 | $3.57M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| AXONreduced | -26,346 | -$13.9M |
| IWMreduced | -45,000 | -$8.98M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q1 2025
Share positions as resolved from 13F-HR 0000919574-25-003088, largest first. % of portfolio is the value over $1,234,437,659, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| MNSTMONSTER BEVERAGE CORP NEW | 8,295,690 | $485M | 39.33% | 0 | Timeline | ||
| AXONAXON ENTERPRISE INC | 696,075 | $366M | 29.66% | -26,346 | Timeline | ||
| STAASTAAR SURGICAL CO | 12,455,264 | $220M | 17.79% | +1,606,633 | Timeline | ||
| IWMISHARES TR | 474,920 | $94.7M | 7.67% | -45,000 | Timeline | ||
| IMDXINSIGHT MOLECULAR DIA INC | 11,410,100 | $34.9M | 2.83% | +5,165,695 | Timeline | ||
| LCTXLINEAGE CELL THERAPEUTICS IN | 49,560,992 | $22.4M | 1.81% | +7,894,737 | Timeline | ||
| OLO INCOLO INC | 1,782,334 | $10.8M | 0.87% | new | |||
| SERSERINA THERAPEUTICS INC | 85,219 | $483K | 0.04% | 0 | Timeline |
How Q1 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000919574-25-003088 | base | 2025-05-15 | acceptance time not in the bulk data set |